Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of cyclic adenosine monophosphate compound and its pharmaceutical composition of cyclic adenosine monophosphate meglumine

A cyclic adenosine phosphate compound and the technology of the cyclic adenosine phosphate compound are applied in the field of medicine and can solve the problems of poor stability, unstable insoluble particles and the like, and achieve the effect of improving stability

Active Publication Date: 2015-10-14
湖北美林药业有限公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The prior art meglumine cyclic adenosine monophosphate injection has the disadvantages of unstable insoluble particles, easy degradation when exposed to light, and poor stability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of cyclic adenosine monophosphate compound and its pharmaceutical composition of cyclic adenosine monophosphate meglumine
  • A kind of cyclic adenosine monophosphate compound and its pharmaceutical composition of cyclic adenosine monophosphate meglumine
  • A kind of cyclic adenosine monophosphate compound and its pharmaceutical composition of cyclic adenosine monophosphate meglumine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Example 1 Preparation of cyclic adenosine monophosphate compound

[0065] 1. Add cyclic adenosine monophosphate raw materials into pyridine at a weight ratio of 1:3, raise the temperature to 62°C, and stir at 120 rpm to dissolve.

[0066] 2. Cool down to 58°C, and at a stirring speed of 100 rpm, slowly and uniformly add 3 times pyridine in step 1 with a volume ratio of 7:3 to the solution in step 1 while stirring at a speed of 50ml / min. A mixed solution of ethanol and ether, stop stirring after adding the mixed solution, cool down to 2°C at a rate of 0.6°C / min, let stand to grow crystals for 8 hours, and filter.

[0067] 3. Wash the filter cake obtained by filtering in 2 twice with 2 times the weight of ethanol, and dry at 60° C. for 6 hours to obtain the cyclic adenosine monophosphate compound.

[0068] X-ray powder diffraction pattern see attached figure 1 , the characteristic peaks in the spectrum at 2θ±0.2° are 5.8°, 6.9°, 7.6°, 11.3°, 16.5°, 19.2°, 21.7°, 22.6°, ...

Embodiment 2

[0069] Example 2 Preparation of cyclic adenosine monophosphate compound

[0070] 1. Add cyclic adenosine monophosphate raw materials into pyridine at a weight ratio of 1:3, raise the temperature to 67°C, and stir at 150 rpm to dissolve.

[0071] 2. Cool down to 60°C, and at a stirring speed of 120 rpm, slowly and uniformly add 4 times the weight of pyridine in step 1 with a volume ratio of 7:3 to the solution in step 1 while stirring at a speed of 60ml / min. A mixed solution of ethanol and ether, stop stirring after adding the mixed solution, cool down to 4°C at a rate of 0.8°C / min, let stand to grow crystals for 8 hours, and filter.

[0072] 3. Wash the filter cake obtained by filtering in 2 twice with 2 times the weight of ethanol, and dry at 5° C. for 6 hours to obtain the cyclic adenosine monophosphate compound.

[0073] The X-ray powder diffraction pattern is consistent with Example 1. Content: 99.97%. Melting point: 262~265℃, water solubility 92.8mg / ml.

Embodiment 3

[0074] Example 3 Preparation of cyclic adenosine monophosphate injection, specification: 2ml: 20mg.

[0075] prescription:

[0076] Cyclic adenosine monophosphate compound: 20g

[0077] L-malic acid: 1g

[0078] Sodium tartrate: 0.5g

[0079] Add water for injection to 2000ml

[0080] ________________________

[0081] Make 1000 pieces

[0082] The preparation method is:

[0083] 1. Add water for injection to 1600ml, adjust the water temperature to 50°C, add the prescribed amount of cyclic adenosine monophosphate compound, L-malic acid, and sodium tartrate to dissolve, cool down to 22°C and adjust the pH to 5.8 with sodium hydroxide.

[0084] 2. Add water for injection to 2000ml, stir evenly, filter with a 0.22 μm filter membrane, fill according to the specifications, melt seal, sterilize with damp heat at 121°C for 15 minutes, pack after passing the inspection, and prepare the active ingredient as the ring of the present invention. Adenosine Phosphate Compound Injection...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a cyclic adenosine monophosphate compound and a cyclic adenosine monophosphate meglumine pharmaceutical composition. The cyclic adenosine monophosphate compound of the present invention is a crystal, which is measured by X-ray powder diffraction. The characteristic peaks in the spectrum are 5.8°, 6.9°, 7.6°, 11.3°, 16.5°, 19.2°, 21.7°, 2θ±0.2°, 22.6°, 24.0°, 25.9°, 30.1°, 31.2°, 33.4° display. The present invention also provides the injection of the cyclic adenosine monophosphate compound, the composition injection of adenosine cyclic monophosphate meglumine and the injection of the cyclic adenosine monophosphate meglumine glucose composition as the active ingredient. Compared with the prior art, the stability of the cyclic adenosine monophosphate injection of the present invention is significantly improved, and the addition of L-malic acid and sodium tartrate in the prescription can further improve the stability.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a cyclic adenosine monophosphate compound and a cyclic adenosine monophosphate meglumine pharmaceutical composition. Background technique [0002] Cyclic adenosine monophosphate is a protein kinase activator, which is a derivative of nucleotides. It is an important substance with physiological activity that widely exists in the human body. It is produced by adenosine triphosphate under the catalysis of adenylyl cyclase and can regulate various functional activities of cells. As the second messenger of hormones, hormones regulate physiological functions and substance metabolism in cells, can change the function of cell membranes, and promote calcium ions in the reticulum sarcoplasm to enter muscle fibers, thereby enhancing myocardial contraction and promoting oxygenation of the respiratory chain Enzyme activity can improve myocardial hypoxia, relieve symptoms of coronary heart dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/213C07H1/06A61K31/7076A61K9/08A61K47/12A61K47/26
Inventor 胡成忠李冰刘键
Owner 湖北美林药业有限公司